 | • レポートコード：QYR9ST04892 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、高コレステロール血症治療の世界市場について調査・分析し、高コレステロール血症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）、用途別（診療所、病院、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の高コレステロール血症治療市場動向 ・主要企業別マーケットシェア ・高コレステロール血症治療の種類別市場規模2014-2019 （AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他） ・高コレステロール血症治療の用途別市場規模2014-2019 （診療所、病院、その他） ・高コレステロール血症治療の北米市場：主要企業・種類別/用途別市場規模 ・高コレステロール血症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・高コレステロール血症治療の中国市場：主要企業・種類別/用途別市場規模 ・高コレステロール血症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・高コレステロール血症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・高コレステロール血症治療のインド市場：主要企業・種類別/用途別市場規模 ・高コレステロール血症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （CymaBay Therapeutics Inc、Daewoong Co Ltd、Gemphire Therapeutics Inc、LipimetiX Development Inc、Regeneron Pharmaceuticals Inc、RegenxBio Inc、The Medicines Company） ・高コレステロール血症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. Presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases. Hypercholesterolemia is caused due to a combination of genetic and environmental factors. Environmental factors include excessive diet intake and obesity. In case of genetic factors, the number of copies of the gene determines the severity of the disease. People with the homozygous form (two copies of the gene) generally suffer from severe cardiovascular diseases during childhood, while those with the heterozygous form (with a single copy of the gene) suffer from heart diseases in their 30s or 40s.In 2018, the global Hypercholesterolemia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hypercholesterolemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypercholesterolemia Treatment development in United States, Europe and China.
The key players covered in this study
CymaBay Therapeutics Inc
Daewoong Co Ltd
Gemphire Therapeutics Inc
LipimetiX Development Inc
Regeneron Pharmaceuticals Inc
RegenxBio Inc
The Medicines Company
…
Market segment by Type, the product can be split into
AEM-2802
AEM-2814
Alirocumab
Evinacumab
Others
Market segment by Application, split into
Clinic
Hospital
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hypercholesterolemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Hypercholesterolemia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hypercholesterolemia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hypercholesterolemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 AEM-2802
1.4.3 AEM-2814
1.4.4 Alirocumab
1.4.5 Evinacumab
1.4.6 Others
1.5 Market by Application
1.5.1 Global Hypercholesterolemia Treatment Market Share by Application (2014-2025)
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hypercholesterolemia Treatment Market Size
2.2 Hypercholesterolemia Treatment Growth Trends by Regions
2.2.1 Hypercholesterolemia Treatment Market Size by Regions (2014-2025)
2.2.2 Hypercholesterolemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hypercholesterolemia Treatment Market Size by Manufacturers
3.1.1 Global Hypercholesterolemia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Hypercholesterolemia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hypercholesterolemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Hypercholesterolemia Treatment Key Players Head office and Area Served
3.3 Key Players Hypercholesterolemia Treatment Product/Solution/Service
3.4 Date of Enter into Hypercholesterolemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hypercholesterolemia Treatment Market Size by Type (2014-2019)
4.2 Global Hypercholesterolemia Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Hypercholesterolemia Treatment Market Size (2014-2019)
5.2 Hypercholesterolemia Treatment Key Players in United States
5.3 United States Hypercholesterolemia Treatment Market Size by Type
5.4 United States Hypercholesterolemia Treatment Market Size by Application
6 Europe
6.1 Europe Hypercholesterolemia Treatment Market Size (2014-2019)
6.2 Hypercholesterolemia Treatment Key Players in Europe
6.3 Europe Hypercholesterolemia Treatment Market Size by Type
6.4 Europe Hypercholesterolemia Treatment Market Size by Application
7 China
7.1 China Hypercholesterolemia Treatment Market Size (2014-2019)
7.2 Hypercholesterolemia Treatment Key Players in China
7.3 China Hypercholesterolemia Treatment Market Size by Type
7.4 China Hypercholesterolemia Treatment Market Size by Application
8 Japan
8.1 Japan Hypercholesterolemia Treatment Market Size (2014-2019)
8.2 Hypercholesterolemia Treatment Key Players in Japan
8.3 Japan Hypercholesterolemia Treatment Market Size by Type
8.4 Japan Hypercholesterolemia Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hypercholesterolemia Treatment Market Size (2014-2019)
9.2 Hypercholesterolemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Hypercholesterolemia Treatment Market Size by Type
9.4 Southeast Asia Hypercholesterolemia Treatment Market Size by Application
10 India
10.1 India Hypercholesterolemia Treatment Market Size (2014-2019)
10.2 Hypercholesterolemia Treatment Key Players in India
10.3 India Hypercholesterolemia Treatment Market Size by Type
10.4 India Hypercholesterolemia Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Hypercholesterolemia Treatment Market Size (2014-2019)
11.2 Hypercholesterolemia Treatment Key Players in Central & South America
11.3 Central & South America Hypercholesterolemia Treatment Market Size by Type
11.4 Central & South America Hypercholesterolemia Treatment Market Size by Application
12 International Players Profiles
12.1 CymaBay Therapeutics Inc
12.1.1 CymaBay Therapeutics Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hypercholesterolemia Treatment Introduction
12.1.4 CymaBay Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)
12.1.5 CymaBay Therapeutics Inc Recent Development
12.2 Daewoong Co Ltd
12.2.1 Daewoong Co Ltd Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hypercholesterolemia Treatment Introduction
12.2.4 Daewoong Co Ltd Revenue in Hypercholesterolemia Treatment Business (2014-2019)
12.2.5 Daewoong Co Ltd Recent Development
12.3 Gemphire Therapeutics Inc
12.3.1 Gemphire Therapeutics Inc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hypercholesterolemia Treatment Introduction
12.3.4 Gemphire Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)
12.3.5 Gemphire Therapeutics Inc Recent Development
12.4 LipimetiX Development Inc
12.4.1 LipimetiX Development Inc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hypercholesterolemia Treatment Introduction
12.4.4 LipimetiX Development Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)
12.4.5 LipimetiX Development Inc Recent Development
12.5 Regeneron Pharmaceuticals Inc
12.5.1 Regeneron Pharmaceuticals Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hypercholesterolemia Treatment Introduction
12.5.4 Regeneron Pharmaceuticals Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)
12.5.5 Regeneron Pharmaceuticals Inc Recent Development
12.6 RegenxBio Inc
12.6.1 RegenxBio Inc Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hypercholesterolemia Treatment Introduction
12.6.4 RegenxBio Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)
12.6.5 RegenxBio Inc Recent Development
12.7 The Medicines Company
12.7.1 The Medicines Company Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hypercholesterolemia Treatment Introduction
12.7.4 The Medicines Company Revenue in Hypercholesterolemia Treatment Business (2014-2019)
12.7.5 The Medicines Company Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hypercholesterolemia Treatment Key Market Segments
Table Key Players Hypercholesterolemia Treatment Covered
Table Global Hypercholesterolemia Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hypercholesterolemia Treatment Market Size Market Share by Type 2014-2025
Figure AEM-2802 Figures
Table Key Players of AEM-2802
Figure AEM-2814 Figures
Table Key Players of AEM-2814
Figure Alirocumab Figures
Table Key Players of Alirocumab
Figure Evinacumab Figures
Table Key Players of Evinacumab
Figure Others Figures
Table Key Players of Others
Table Global Hypercholesterolemia Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinic Case Studies
Figure Hospital Case Studies
Figure Others Case Studies
Figure Hypercholesterolemia Treatment Report Years Considered
Table Global Hypercholesterolemia Treatment Market Size 2014-2025 (Million US$)
Figure Global Hypercholesterolemia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hypercholesterolemia Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Hypercholesterolemia Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Hypercholesterolemia Treatment Market Share by Regions 2014-2019
Figure Global Hypercholesterolemia Treatment Market Share by Regions 2014-2019
Figure Global Hypercholesterolemia Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Hypercholesterolemia Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hypercholesterolemia Treatment Market Share by Manufacturers (2014-2019)
Figure Global Hypercholesterolemia Treatment Market Share by Manufacturers in 2018
Table Global Hypercholesterolemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hypercholesterolemia Treatment Product/Solution/Service
Table Date of Enter into Hypercholesterolemia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hypercholesterolemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Hypercholesterolemia Treatment Market Size Share by Type (2014-2019)
Figure Global Hypercholesterolemia Treatment Market Size Market Share by Type (2014-2019)
Table Global Hypercholesterolemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Hypercholesterolemia Treatment Market Size Share by Application (2014-2019)
Figure Global Hypercholesterolemia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Hypercholesterolemia Treatment Revenue Market Share by Application in 2018
Figure United States Hypercholesterolemia Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Hypercholesterolemia Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Hypercholesterolemia Treatment Market Share (2018-2019)
Table United States Hypercholesterolemia Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Hypercholesterolemia Treatment Market Share by Type (2014-2019)
Table United States Hypercholesterolemia Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Hypercholesterolemia Treatment Market Share by Application (2014-2019)
Figure Europe Hypercholesterolemia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Hypercholesterolemia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Hypercholesterolemia Treatment Market Share (2018-2019)
Table Europe Hypercholesterolemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Hypercholesterolemia Treatment Market Share by Type (2014-2019)
Table Europe Hypercholesterolemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Hypercholesterolemia Treatment Market Share by Application (2014-2019)
Figure China Hypercholesterolemia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Hypercholesterolemia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Hypercholesterolemia Treatment Market Share (2018-2019)
Table China Hypercholesterolemia Treatment Market Size by Type (2014-20189) (Million US$)
Table China Hypercholesterolemia Treatment Market Share by Type (2014-2019)
Table China Hypercholesterolemia Treatment Market Size by Application (2014-2019) (Million US$)
Table China Hypercholesterolemia Treatment Market Share by Application (2014-2019)
Figure Japan Hypercholesterolemia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Hypercholesterolemia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Hypercholesterolemia Treatment Market Share (2018-2019)
Table Japan Hypercholesterolemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Hypercholesterolemia Treatment Market Share by Type (2014-2019)
Table Japan Hypercholesterolemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Hypercholesterolemia Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Hypercholesterolemia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hypercholesterolemia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hypercholesterolemia Treatment Market Share (2018-2019)
Table Southeast Asia Hypercholesterolemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hypercholesterolemia Treatment Market Share by Type (2014-2019)
Table Southeast Asia Hypercholesterolemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hypercholesterolemia Treatment Market Share by Application (2014-2019)
Figure India Hypercholesterolemia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Hypercholesterolemia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Hypercholesterolemia Treatment Market Share (2018-2019)
Table India Hypercholesterolemia Treatment Market Size by Type (2014-2019) (Million US$)
Table India Hypercholesterolemia Treatment Market Share by Type (2014-2019)
Table India Hypercholesterolemia Treatment Market Size by Application (2014-2019) (Million US$)
Table India Hypercholesterolemia Treatment Market Share by Application (2014-2019)
Figure Central & South America Hypercholesterolemia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hypercholesterolemia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hypercholesterolemia Treatment Market Share (2018-2019)
Table Central & South America Hypercholesterolemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hypercholesterolemia Treatment Market Share by Type (2014-2019)
Table Central & South America Hypercholesterolemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hypercholesterolemia Treatment Market Share by Application (2014-2019)
Table CymaBay Therapeutics Inc Company Details
Table CymaBay Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019) (Million US$)
Figure CymaBay Therapeutics Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2014-2019)
Table CymaBay Therapeutics Inc Recent Development
Table Daewoong Co Ltd Company Details
Table Daewoong Co Ltd Revenue in Hypercholesterolemia Treatment Business (2014-2019)(Million US$)
Figure Daewoong Co Ltd Revenue Growth Rate in Hypercholesterolemia Treatment Business (2014-2019)
Table Daewoong Co Ltd Recent Development
Table Gemphire Therapeutics Inc Company Details
Table Gemphire Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)(Million US$)
Figure Gemphire Therapeutics Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2014-2019)
Table Gemphire Therapeutics Inc Recent Development
Table LipimetiX Development Inc Company Details
Table LipimetiX Development Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)(Million US$)
Figure LipimetiX Development Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2014-2019)
Table LipimetiX Development Inc Recent Development
Table Regeneron Pharmaceuticals Inc Company Details
Table Regeneron Pharmaceuticals Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2014-2019)
Table Regeneron Pharmaceuticals Inc Recent Development
Table RegenxBio Inc Company Details
Table RegenxBio Inc Revenue in Hypercholesterolemia Treatment Business (2014-2019)(Million US$)
Figure RegenxBio Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2014-2019)
Table RegenxBio Inc Recent Development
Table The Medicines Company Company Details
Table The Medicines Company Revenue in Hypercholesterolemia Treatment Business (2014-2019)(Million US$)
Figure The Medicines Company Revenue Growth Rate in Hypercholesterolemia Treatment Business (2014-2019)
Table The Medicines Company Recent Development
Table Global Hypercholesterolemia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Hypercholesterolemia Treatment Market Size Share by Regions (2019-2025)
Figure Global Hypercholesterolemia Treatment Market Size Share by Regions in 2025
Figure United States Hypercholesterolemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hypercholesterolemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Hypercholesterolemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hypercholesterolemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hypercholesterolemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Hypercholesterolemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hypercholesterolemia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Hypercholesterolemia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Hypercholesterolemia Treatment Market Size by Product (2019-2025)
Figure Global Hypercholesterolemia Treatment Market Size by Product in 2025
Table Global Hypercholesterolemia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Hypercholesterolemia Treatment Market Size by Application (2019-2025)
Figure Global Hypercholesterolemia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
統合失調感情障害治療の世界市場：市場規模・現状・予測 Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders.The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. In 2018, the global Schizoaffective Disorders Treatment market size was xx million …- 巨細胞性動脈炎治療の世界市場：市場規模・現状・予測 Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin h…
- 院内感染治療の世界市場：市場規模・現状・予測 Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. In 2018, the global Hospital Acquired Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2…
- アルコール性肝炎治療薬の世界市場：市場規模・現状・予測 Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis. The increasing consumption of alco…
- 前立腺癌治療の世界市場：市場規模・現状・予測 Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.In 2018, the global Prostate Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAG…